Gene Therapy for Cardiovascular Disorders
Reference50 articles.
1. Abraham MR, Henrikson CA, Tung L, et al. Antiarrhythmic Engineering of Skeletal Myoblasts for Cardiac Transplantation. Circulation Research 2005;97:159–67.
2. Al-Allaf FA, Coutelle C, Waddington SN, et al. LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives. Int Arch Med 2011; doi: 10.1186/1755-7682-3-36.
3. Athyros VG, Kakafika AI, Tziomalos K, et al. Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster? Expert Opin Investig Drugs 2008;17:969–72.
4. Bell DA, Hooper AJ, Burnett JR. Mipomersen, an antisense apolipoprotein B synthesis inhibitor. Expert Opin Invest Drugs 2011;20:265–272.
5. Bott-Flugel L, Weig HJ, Knodler M, et al. Gene transfer of the pancaspase inhibitor P35 reduces myocardial infarct size and improves cardiac function. J Mol Med 2005;83:526–34.